# Clopidogrel bisulfate

NDC: 82009-021
Generic name: Clopidogrel bisulfate
Labeler / Manufacturer: Quallent Pharmaceuticals Health LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20221115
Marketing ended: 20270228
FDA application: ANDA076273

## Active ingredients

- CLOPIDOGREL BISULFATE: 75 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"82009-021"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=82009-021
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=333c7992-d481-b7d4-404f-9a49c85b6331